Form 8-K - Current report:
SEC Accession No. 0001297184-25-000054
Filing Date
2025-09-18
Accepted
2025-09-18 16:46:54
Documents
12
Period of Report
2025-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K amph-20250915x8k.htm   iXBRL 8-K 52555
  Complete submission text file 0001297184-25-000054.txt   164111

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20250915.xsd EX-101.SCH 3690
3 EX-101.LAB amph-20250915_lab.xml EX-101.LAB 15361
4 EX-101.PRE amph-20250915_pre.xml EX-101.PRE 10385
14 EXTRACTED XBRL INSTANCE DOCUMENT amph-20250915x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 251324110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)